143 results
Page 5 of 8
8-K
ujdv8o
6 May 19
Other Events
4:29pm
8-K
EX-99.2
8puhjte3vd19dpvdie
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
EX-99.1
jiblrw9nw43nd
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
EX-10.1
h2xki1 n45
4 Mar 19
Agile Therapeutics Announces $7.8 Million Private Placement
5:27pm
8-K
EX-99.1
fayjr5w7
11 Feb 19
Company now focused on completing plan to resubmit NDA in first half of 2019
5:00pm
8-K
EX-1.1
vtebcx42he 6031uh
23 Jan 19
Entry into a Material Definitive Agreement
8:04am
424B5
llpowlag
23 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
8tlok
10 Jan 19
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
4:20pm
8-K
EX-99.1
b49d4z7dh fxls52bo
10 Jan 19
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
4:20pm
8-K
EX-99.1
7syt 3how
7 Jan 19
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
f3dw6 4etejs3rtq2
1 Nov 18
Agile Therapeutics Reports Third Quarter 2018 Financial Results
4:31pm
8-K
dzcyug
24 Oct 18
Other Events
8:13am
8-K
EX-99.1
z4v95ujyj n8
24 Oct 18
Other Events
8:13am
8-K
EX-99.1
oknppd75tjtyn2prbc
9 Oct 18
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
8:09am
8-K
gpgkrbxsn5zba3
9 Oct 18
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
8:09am